Delivery Order SPE2DB20D1102-SPE2DB25FC5VM

Award Date 12/17/24
Potential Completion Date 12/18/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB20D1102
    Indefinite Delivery Contract
  • SPE2DB20D1102-SPE2DB25FC5VM
    Delivery Order

This federal contract award, with ID SPE2DB20D1102|SPE2DB25FC5VM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,105.78 firm fixed-price delivery order is for the supply of 4566748547 - Clindamycin 900 mg/50 ml-D5W 50 ml.

The contract has an ultimate completion date of December 18, 2024 and was awarded on December 17, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization registered in the System for Award Management (SAM.gov) through June 11, 2025.

This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 3/18/25, 9:57 AM